Hill-Rom Hlds

Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL.

Abbott Labs

Hologic

IDEXX Laboratories

LeMaitre Vascular

Here are a few MedTech stocks, ABT, HOLX, HRC, IDXX, LMAT, which have held their ground amid the pandemic and can turn out to be wise investment choices for 2021.

5 MedTech Growth Stocks Gaining Ground in 2021 Amid Pandemic

BioLife Solutions

HRC vs. BLFS: Which Stock Is the Better Value Option?

Colgate-Palmolive

CSG Systems International

Dick's Sporting Goods

Equity LifeStyle Properties

Hurco Companies

Kadant

Oracle

TE Connectivity PLC

A table with relevant data and key statistics of dividend increases is provided.

Dividend Increases: March 6-12, 2021

CHICAGO, March 11, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) announced today that its board of directors declared a 9 percent increase in the company's quarterly dividend rate, from the previous rate of $0.22 per share to $0.24 per share. The fiscal second quarter 2021 quarterly dividend is payable on March 31, 2021, to shareholders of record as of the close of business on March 22, 2021.

Hillrom Announces 9 Percent Increase in Quarterly Dividend

CHICAGO, March 10, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced that it will present at KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum on Tuesday, March 23, 2021. John Groetelaars, Hillrom's president and chief executive officer, will participate in a fireside chat at 10:00 a.m.

Hillrom to Present at KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum

Hill-Rom (HRC) reported earnings 30 days ago. What's next for the stock?

Why Is Hill-Rom (HRC) Up 6.6% Since Last Earnings Report?

Aflac

Conagra Brands

ICU Medical

SJW Group

As bond yields pop and the rotation out of tech into recovery plays continues, Q.ai's Artificial Intelligence has brought you today's top buys.

Top Stocks To Buy Today As The Reopening Rotation Continues

CHICAGO, March 1, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today provided an update on its planned acquisition of Bardy Diagnostics, Inc. (BardyDx), which it previously announced on January 19, 2021. On January 29, 2021, a Medicare Administrative Contractor, Novitas Solutions, published...

Hillrom Provides Update on Planned Acquisition of Bardy Diagnostics, Inc.

HRC vs. BLFS: Which Stock Should Value Investors Buy Now?

Hill-Rom Holdings (HRC) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Moving Average Crossover Alert: Hill-Rom Holdings (HRC)

Hill-Rom (HRC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Earnings Estimates Rising for Hill-Rom (HRC): Will It Gain?

Hill-Rom's (HRC) first-quarter fiscal 2021 revenue climbed 8.2% year over year to $741.1 million.

Hill-Rom's (HRC) Q1 Earnings Beat Estimates, Margins Up

Hill-Rom Holdings, Inc. (HRC) CEO John Groetelaars on Q1 2021 Results - Earnings Call Transcript

Hill-Rom (HRC) delivered earnings and revenue surprises of 45.71% and 13.21%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Hill-Rom (HRC) Beats Q1 Earnings and Revenue Estimates

Shares of Hill-Rom Holdings (NYSE:HRC) rose 0.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 35.40% year over year to $1.53, which beat the estimate of $1.05.

Recap: Hill-Rom Q1 Earnings

CHICAGO, Feb. 5, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced financial results for its fiscal first quarter ended December 31, 2020, and raised its fiscal 2021 guidance. For the fiscal first quarter, Hillrom reported GAAP earnings of $0.88 per diluted share compared to $0.59...

Hillrom's Fiscal First Quarter Financial Results Exceed Guidance

CHICAGO, Jan. 31, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) previously announced its intention to acquire Bardy Diagnostics, Inc. (BardyDx), an innovator in digital health and a leading provider of ambulatory cardiac monitoring. On January 29, 2021, a Medicare Administrative Contractor...

Hillrom Comments On Novitas Reimbursement Decision

Hill-Rom's (HRC) acquisition of Bardy Diagnostics enables the former to expand into ambulatory cardiac monitoring space to accelerate digital health offering.

Hill-Rom (HRC) to Boost Cardiology Portfolio with New Buyout

CHICAGO, Jan. 19, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced it has reached a definitive agreement to acquire Bardy Diagnostics, Inc. (BardyDx), an innovator in digital health and a leading provider of ambulatory cardiac monitoring technologies. Under the terms of the...

Hillrom Announces Planned Acquisition Of Bardy Diagnostics, Inc.

Becton, Dickinson and Co.

Cardinal Health

McKesson

Here we discuss four dividend-paying value stocks, MCK, CAH, BDX and HRC, which though trading cheap now, have solid chances of a rebound in the second half of 2021.

4 Dividend-Paying Undervalued MedTech Stocks for Gains in 2021

CHICAGO, Jan. 7, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) will host its fiscal first quarter 2021 earnings conference call and webcast on Friday, February 5, 2021, beginning at 7:30 a.m. (CT) / 8:30 a.m. (ET). Conference Call Audio Only Dial-in Information: To participate in the...

Hillrom To Host Fiscal First Quarter 2021 Earnings Conference Call And Webcast

Hill-Rom (HRC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Hill-Rom (HRC) Could Beat Earnings Estimates Again

Let's see if Hill-Rom Holdings (HRC) stock is a good choice for value-oriented investors right now from multiple angles.

Is Hill-Rom Holdings (HRC) a Worthy Pick for Value Investors?

Why Is Hill-Rom (HRC) Up 9.3% Since Last Earnings Report?

Within Front Line Care (FLC), Hill-Rom (HRC) registers growth in vital signs monitoring, blood pressure and thermometry as well as the completion of the U.S. stockpile order for noninvasive ventilators.

News for Hill-Rom Hlds Stock (HRC)